Detailed Information
Cited 2 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Lazertinib as a Frontline Treatment in Patients with EGFR Mutant Advanced Non-Small Cell Lung Cancer: Results from the Phase I/II Trial
- Authors
- Cho, B. C.; Han, J. -Y.; Lee, K. H.; Lee, Y. -G.; Kim, D. -W.; Min, Y. J.; Kim, S. -W.; Cho, E. K.; Kim, J. -H.; Lee, G. -W.; Lee, S. S.; Lee, N. M.; Jang, H. W.; Ahn, M. -J.
- Issue Date
- Sep-2022
- Publisher
- Elsevier Inc.
- Keywords
- Lazertinib; NSCLC; EGFR-TKI
- Citation
- Journal of Thoracic Oncology, v.17, no.9, pp S408 - S409
- Indexed
- SCIE
SCOPUS
- Journal Title
- Journal of Thoracic Oncology
- Volume
- 17
- Number
- 9
- Start Page
- S408
- End Page
- S409
- ISSN
- 1556-0864
1556-1380
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medicine > Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.